227 related articles for article (PubMed ID: 27771632)
1. The Need and Potential of Inactivated Poliovirus Vaccine.
Garon J; Orenstein W; John TJ
Indian Pediatr; 2016 Aug; 53 Suppl 1():S2-S6. PubMed ID: 27771632
[TBL] [Abstract][Full Text] [Related]
2. Eradicating polio: how the world's pediatricians can help stop this crippling illness forever.
Orenstein WA;
Pediatrics; 2015 Jan; 135(1):196-202. PubMed ID: 25548328
[TBL] [Abstract][Full Text] [Related]
3. Modeling the potential role of inactivated poliovirus vaccine to manage the risks of oral poliovirus vaccine cessation.
Duintjer Tebbens RJ; Thompson KM
J Infect Dis; 2014 Nov; 210 Suppl 1():S485-97. PubMed ID: 25316871
[TBL] [Abstract][Full Text] [Related]
4. [Polio vaccines, eradication and posterradication].
Salmerón García F; Portela Moreira A; Soler Soneira M; López Hernández S; Chamorro Somoza Díaz-Sarmiento M; Pérez González I; Rubio Gómez MI; Pérez González A; Sagredo Rodríguez A; Ruiz Antúnez S; Timón Jiménez M; Frutos Cabanillas G
Rev Esp Salud Publica; 2013; 87(5):497-505. PubMed ID: 24322286
[TBL] [Abstract][Full Text] [Related]
5. The polio endgame: rationale behind the change in immunisation.
Garon J; Patel M
Arch Dis Child; 2017 Apr; 102(4):362-365. PubMed ID: 28096107
[TBL] [Abstract][Full Text] [Related]
6. Introduction of inactivated poliovirus vaccine into oral poliovirus vaccine-using countries.
Wkly Epidemiol Rec; 2003 Jul; 78(28):241-50. PubMed ID: 15571166
[TBL] [Abstract][Full Text] [Related]
7. Introduction of Inactivated Poliovirus Vaccine in National Immunization Program and Polio Endgame Strategy.
; Vashishtha VM; Choudhary J; Yadav S; Unni JC; Jog P; Kamath SS; Sachdeva A; Srirampur S; Prajapati B; Parekh BJ
Indian Pediatr; 2016 Aug; 53 Suppl 1():S65-S69. PubMed ID: 27133231
[TBL] [Abstract][Full Text] [Related]
8. Polio endgame: the global introduction of inactivated polio vaccine.
Patel M; Zipursky S; Orenstein W; Garon J; Zaffran M
Expert Rev Vaccines; 2015 May; 14(5):749-62. PubMed ID: 25597843
[TBL] [Abstract][Full Text] [Related]
9. Global Polio Eradication,The Journey So Far.
Thacker N; Yewale VN; Pathak A
Indian Pediatr; 2016 Aug; 53 Suppl 1():S61-S64. PubMed ID: 27771642
[TBL] [Abstract][Full Text] [Related]
10. [The role of Sabin inactivated poliovirus vaccine in the final phase of global polio eradication].
Dong SZ; Zhu WB
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Dec; 50(12):1032-1035. PubMed ID: 28057104
[TBL] [Abstract][Full Text] [Related]
11. Experience With Inactivated Polio Vaccine Introduction and the "Switch" From Trivalent to Bivalent Oral Polio Vaccine in the World Health Organization's Western Pacific Region.
Gurung S; Harris JB; Eltayeb AO; Hampton LM; Diorditsa S; Avagyan T; Schluter WW
J Infect Dis; 2017 Jul; 216(suppl_1):S101-S108. PubMed ID: 28838170
[TBL] [Abstract][Full Text] [Related]
12. Polio endgame: the global switch from tOPV to bOPV.
Garon J; Seib K; Orenstein WA; Ramirez Gonzalez A; Chang Blanc D; Zaffran M; Patel M
Expert Rev Vaccines; 2016 Jun; 15(6):693-708. PubMed ID: 26751187
[TBL] [Abstract][Full Text] [Related]
13. A developing country perspective on vaccine-associated paralytic poliomyelitis.
John TJ
Bull World Health Organ; 2004 Jan; 82(1):53-7; discussion 57-8. PubMed ID: 15106301
[TBL] [Abstract][Full Text] [Related]
14. India's Preparedness for Introduction of IPV and Switch from tOPV to bOPV.
Haldar P; Agrawal P
Indian Pediatr; 2016 Aug; 53 Suppl 1():S44-S49. PubMed ID: 27771639
[TBL] [Abstract][Full Text] [Related]
15. Coverage estimates and patterns of inactivated poliovirus vaccine (IPV) use prior to and during the polio eradication endgame, Jinan City, China, 2010-2015.
Chang C; Zhang J; Zhou J; Cao R; Song K; Liu C; Zhang X; Geng X; Liu X; Li C
Hum Vaccin Immunother; 2016 Nov; 12(11):2749-2752. PubMed ID: 27437792
[TBL] [Abstract][Full Text] [Related]
16. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR Recomm Rep; 1997 Jan; 46(RR-3):1-25. PubMed ID: 9026708
[TBL] [Abstract][Full Text] [Related]
17. Addressing the Challenges and Opportunities of the Polio Endgame: Lessons for the Future.
Patel M; Cochi S
J Infect Dis; 2017 Jul; 216(suppl_1):S1-S8. PubMed ID: 28838196
[TBL] [Abstract][Full Text] [Related]
18. National introduction of fractional-dose inactivated polio vaccine in Sri Lanka following the global "switch".
Gamage D; Ginige S; Palihawadana P
WHO South East Asia J Public Health; 2018 Sep; 7(2):79-83. PubMed ID: 30136665
[TBL] [Abstract][Full Text] [Related]
19. [Universal use of inactivated poliovirus vaccine--the needs and challenges].
Shimizu H; Takeda N
Nihon Rinsho; 2008 Oct; 66(10):1950-5. PubMed ID: 18939495
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of New Primary Immunization Schedules With Inactivated Poliovirus Vaccine and Bivalent Oral Polio Vaccine for the Polio Endgame: A Review.
Bandyopadhyay AS; Modlin JF; Wenger J; Gast C
Clin Infect Dis; 2018 Oct; 67(suppl_1):S35-S41. PubMed ID: 30376081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
